These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2518852)

  • 1. The effect of tripotassium dicitrato bismuthate on pepsin activity.
    De Beaux AC; Defize J; Hunt RH
    Aliment Pharmacol Ther; 1989 Aug; 3(4):381-5. PubMed ID: 2518852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some effects of tripotassium dicitrato bismuthate on gastric secretion and the mucus barrier.
    Sidebotham RL; Batten JJ; Li K; Spencer J; Baron JH
    Aliment Pharmacol Ther; 1990 Oct; 4(5):535-46. PubMed ID: 2129641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
    Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
    Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric pharmacological activities of tripotassium dicitrato bismuthate in rats and dogs.
    Soldani G; Del Tacca M; Bernardini C; Polloni A; Martinotti E; Malandrino S; Borsa M; Tonon GC
    Pharmacol Res Commun; 1985 Nov; 17(11):1017-26. PubMed ID: 3937162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of tripotassium dicitrato bismuthate on the rat stomach.
    Waldum HL; Qvigstad G; Mårvik R; Brenna E; Syversen U; Sandvik AK
    Aliment Pharmacol Ther; 1994 Aug; 8(4):425-31. PubMed ID: 7527257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori: treatment with combinations of pivampicillin and tripotassium dicitrato bismuthate.
    Weil J; Bell GD; Powell K; Morden A; Harrison G; Gant PW; Trowell JE; Burridge S
    Aliment Pharmacol Ther; 1991 Oct; 5(5):543-7. PubMed ID: 1793785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
    Pearson JP; Roberts NB
    Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.
    Gavey CJ; Szeto ML; Nwokolo CU; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1989 Feb; 3(1):21-8. PubMed ID: 2491455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol).
    Hollanders D; Morrissey SM; Mehta J
    Br J Clin Pract; 1983 Mar; 37(3):112-4. PubMed ID: 6882629
    [No Abstract]   [Full Text] [Related]  

  • 12. Omeprazole-induced increase in the absorption of bismuth from tripotassium dicitrato bismuthate.
    Treiber G; Walker S; Klotz U
    Clin Pharmacol Ther; 1994 May; 55(5):486-91. PubMed ID: 8181192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
    Bell GD; Powell K; Burridge SM; Harrison G; Weil J; Gant PW; Jones PH; Trowell JE
    Aliment Pharmacol Ther; 1992 Jun; 6(3):327-33. PubMed ID: 1600049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine.
    Hamilton I; O'Connor HJ; Wood NC; Bradbury I; Axon AT
    Gut; 1986 Jan; 27(1):106-10. PubMed ID: 3512382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer.
    Chearanai O; Kachintorn U; Plengvanit U
    J Med Assoc Thai; 1987 Apr; 70(4):176-80. PubMed ID: 3612003
    [No Abstract]   [Full Text] [Related]  

  • 16. Tripotassium dicitrato bismuthate: absorption and urinary excretion of bismuth in patients with normal and impaired renal function.
    Treiber G; Gladziwa U; Ittel TH; Walker S; Schweinsberg F; Klotz U
    Aliment Pharmacol Ther; 1991 Oct; 5(5):491-502. PubMed ID: 1793780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR
    Gut; 1982 Jul; 23(7):621-4. PubMed ID: 7044913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
    Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O
    Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma bismuth levels after oral dosing with basic bismuth carbonate or tripotassium dicitrato bismuthate.
    Madaus S; Schulte-Frohlinde E; Scherer C; Kämmereit A; Schusdziarra V; Classen M
    Aliment Pharmacol Ther; 1992 Apr; 6(2):241-9. PubMed ID: 1288519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.